{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:31:11Z","timestamp":1793053871303,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.rvsc.2023.03.026","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:48:59Z","timestamp":1680522539000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Population pharmacokinetics and pharmacokinetic\/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats"],"prefix":"10.1016","volume":"159","author":[{"given":"Juan Manuel","family":"Serrano-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Fern\u00e1ndez-Var\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Mario C\u00e1rceles","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Ignacio San","family":"Andr\u00e9s-Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rubio-Langre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"de la Fe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta Waxman","family":"Dova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritam Kaur","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s Javier","family":"Litterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto Mat\u00edas","family":"Lorenzutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2023.03.026_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.rvsc.2023.03.026_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2885.2002.00399.x","article-title":"Pharmacokinetics and pharmacokinetic\/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate","volume":"25","author":"AliAbadi","year":"2002","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.rvsc.2018.10.010","article-title":"Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats","volume":"121","author":"Bhardwaj","year":"2018","journal-title":"Res. Vet. Sci."},{"issue":"4","key":"10.1016\/j.rvsc.2023.03.026_bb0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/jvp.12776","article-title":"Pharmacokinetic\u2013pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats","volume":"42","author":"Bhardwaj","year":"2019","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jvp.12473","article-title":"Mathematical modeling and simulation in animal health. Part III: using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics","volume":"41","author":"Bon","year":"2018","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.rvsc.2023.03.026_bb0035","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/evj.13385","article-title":"Determination of the pharmacokinetic-pharmacodynamic cut-off values of marbofloxacin in horses to support the establishment of a clinical breakpoint for antimicrobial susceptibility testing","volume":"53","author":"Bousquet-M\u00e9lou","year":"2021","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0040","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2017"},{"issue":"3","key":"10.1016\/j.rvsc.2023.03.026_bb0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/jvp.12849","article-title":"Effect of supportive therapy on the pharmacokinetics of intravenous marbofloxacin in endotoxemic sheep","volume":"43","author":"Coskun","year":"2020","journal-title":"J. Vet. Pharmacol. Ther. May"},{"key":"10.1016\/j.rvsc.2023.03.026_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.phrs.2018.07.005","article-title":"Clinical applications of population pharmacokinetic models of antibiotics: challenges and perspectives","volume":"134","author":"de Velde","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tvjl.2006.05.004","article-title":"Pharmacokinetic behavior and pharmacokinetic\/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats","volume":"174","author":"Dova","year":"2007","journal-title":"Vet. J."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0060","author":"European Medicines Agency"},{"key":"10.1016\/j.rvsc.2023.03.026_bb0065","author":"European Medicines Agency"},{"key":"10.1016\/j.rvsc.2023.03.026_bb0070","author":"European Medicines Agency"},{"issue":"4","key":"10.1016\/j.rvsc.2023.03.026_bb0080","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/ani11041104","article-title":"PK\/PD analysis of Marbofloxacin by Monte Carlo simulation against Mycoplasma agalactiae in plasma and milk of lactating goats after IV, SC and SC-long acting formulations administration","volume":"11","author":"Fern\u00e1ndez-Var\u00f3n","year":"2021","journal-title":"Animals"},{"issue":"4","key":"10.1016\/j.rvsc.2023.03.026_bb0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/antibiotics11040427","article-title":"Antimicrobial susceptibility testing: a comprehensive review of currently used methods","volume":"11","author":"Gajic","year":"2022","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.rvsc.2023.03.026_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.ARBA-0030-2018","article-title":"Antimicrobial resistance in Mycoplasma spp","volume":"6","author":"Gautier-Bouchardon","year":"2018","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jcph.1650","article-title":"Nonparametric methods in population pharmacokinetics","volume":"62","author":"Goutelle","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0100","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/01621459.1995.10476572","article-title":"Bayes factors","volume":"90","author":"Kass","year":"1995","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0105","series-title":"Mixed Effects Models for the Population Approach: Models, Tasks, Methods and Tools","author":"Lavielle","year":"2015"},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","article-title":"EUCAST expert rules in antimicrobial susceptibility testing","volume":"19","author":"Leclercq","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"issue":"6","key":"10.1016\/j.rvsc.2023.03.026_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jvp.12409","article-title":"Pharmacokinetics, milk penetration and PK\/PD analysis by Monte Carlo simulation of marbofloxacin, after intravenous and intramuscular administration to lactating goats","volume":"40","author":"Lorenzutti","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.rvsc.2023.03.026_bb0120","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.3390\/ani11113098","article-title":"PK\/PD analysis by nonlinear mixed-effects modeling of a marbofloxacin dose regimen for treatment of goat mastitis produced by coagulase-negative staphylococci","volume":"11","author":"Lorenzutti","year":"2021","journal-title":"Animals"},{"issue":"11","key":"10.1016\/j.rvsc.2023.03.026_bb0125","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/antibiotics10111290","article-title":"Effects of growth medium and inoculum size on pharmacodynamics activity of marbofloxacin against Staphylococcus aureus isolated from caprine clinical mastitis","volume":"10","author":"Lorenzutti","year":"2021","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2885.2011.01313.x","article-title":"ABCG2 transporter: therapeutic and physiologic implications in veterinary species","volume":"35","author":"Mealey","year":"2012","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.rvsc.2023.03.026_bb0135","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/dmd.105.008219","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion","volume":"34","author":"Merino","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0140","series-title":"Pharmacodynamics of Antimicrobials against Mycoplasma mycoides mycoides Small Colony, the Causative Agent of Contagious Bovine Pleuropneumonia","author":"Mitchell","year":"2012"},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.107.018747","article-title":"Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer","volume":"36","author":"Morgan","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.rvsc.2023.03.026_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2012.4","article-title":"Basic concepts in population modeling, simulation, and model-based drug development","volume":"1","author":"Mould","year":"2012","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"4","key":"10.1016\/j.rvsc.2023.03.026_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development\u2014part 2: introduction to pharmacokinetic modeling methods","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"11","key":"10.1016\/j.rvsc.2023.03.026_bb0160","first-page":"1591","article-title":"Antimicrobial and methicillin resistance pattern of potential mastitis-inducing Staphylococcus aureus and coagulase-negative staphylococci isolates from the mammary secretion of dairy goats","volume":"11","author":"Nelli","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.rvsc.2023.03.026_bb0165","author":"OIE (World Organisation for Animal Health)"},{"key":"10.1016\/j.rvsc.2023.03.026_bb0170","series-title":"Introduction to Population Pharmacokinetic\/Pharmacodynamic Analysis with Nonlinear Mixed Effects Models","author":"Owen","year":"2014"},{"key":"10.1016\/j.rvsc.2023.03.026_bb0175","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.vetmic.2013.12.021","article-title":"Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs","volume":"171","author":"Papich","year":"2014","journal-title":"Vet. Microbiol."},{"issue":"1","key":"10.1016\/j.rvsc.2023.03.026_bb0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jvp.12418","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of marbofloxacin as a single injection for Pasteurellaceae respiratory infections in cattle using population pharmacokinetics and Monte Carlo simulations","volume":"41","author":"Paulin","year":"2018","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.rvsc.2023.03.026_bb0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/psp4.12141","article-title":"Modeling of large pharmacokinetic data using nonlinear mixed-effects: a paradigm shift in veterinary pharmacology. A case study with robenacoxib in cats","volume":"5","author":"Pelligand","year":"2016","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tvjl.2012.09.012","article-title":"Inhibition of ABCG2\/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep","volume":"196","author":"Perez","year":"2013","journal-title":"Vet. J."},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/mi.7.2.10","article-title":"Regulation of drug transporters: during infection and inflammation","volume":"7","author":"Petrovic","year":"2007","journal-title":"Mol. Interv."},{"issue":"4","key":"10.1016\/j.rvsc.2023.03.026_bb0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2885.2006.00744.x","article-title":"Interaction of enrofloxacin with breast cancer resistance protein (BCRP\/ABCG2): influence of flavonoids and role in milk secretion in sheep","volume":"29","author":"Pulido","year":"2006","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.rvsc.2023.03.026_bb0205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2885.2010.01241.x","article-title":"Involvement of breast cancer resistance protein (BCRP\/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin","volume":"34","author":"Real","year":"2011","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.rvsc.2023.03.026_bb0210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425255.1.4.629","article-title":"Regulation of drug metabolism and disposition during inflammation and infection","volume":"1","author":"Renton","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0215","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00228-011-1023-6","article-title":"Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk","volume":"67","author":"Salman","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.smallrumres.2019.08.012","article-title":"Marbofloxacin pharmacokinetics in goats during the lactation","volume":"179","author":"S\u00e1nchez","year":"2019","journal-title":"Small Rumin. Res."},{"issue":"6","key":"10.1016\/j.rvsc.2023.03.026_bib321","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/clpt.2008.62","article-title":"Effects of inflammation on pharmacokinetics\/pharmacodynamics: increasing recognition of its contribution to variability in response","volume":"83","author":"Schmith","year":"2008","journal-title":"Clin. Pharmacol. Therap."},{"issue":"2\u20133","key":"10.1016\/j.rvsc.2023.03.026_bb0225","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejphar.2008.03.014","article-title":"Implications of ABC transporters on the disposition of typical veterinary medicinal products","volume":"585","author":"Schrickx","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.rvsc.2023.03.026_bb0230","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/vr.103964","article-title":"Susceptibility and PK\/PD relationships of Staphylococcus aureus strains isolated from the milk of sheep and goats with clinical mastitis to five veterinary fluoroquinolones","volume":"180","author":"Serrano-Rodr\u00edguez","year":"2017","journal-title":"Vet. Rec."},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tvjl.2009.02.009","article-title":"Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in goats","volume":"184","author":"Sidhu","year":"2010","journal-title":"Vet. J."},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01068080","article-title":"Analysis of the contributions of permeability and flow to intercompartmental clearance","volume":"9","author":"Stec","year":"1981","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"6","key":"10.1016\/j.rvsc.2023.03.026_bb0250","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2885.2004.00605.x","article-title":"Plasma clearance","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0255","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3389\/fmicb.2017.02344","article-title":"En route towards European clinical breakpoints for veterinary antimicrobial susceptibility testing: a position paper explaining the VetCAST approach","volume":"8","author":"Toutain","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0260","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fmicb.2019.01310","article-title":"VetCAST method for determination of the pharmacokinetic-pharmacodynamic cut-off values of a long-acting formulation of florfenicol to support clinical breakpoints for florfenicol antimicrobial susceptibility testing in cattle","volume":"10","author":"Toutain","year":"2019","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.rvsc.2023.03.026_bb0265","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jvp.12917","article-title":"The pharmacokinetic\/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: recent advances and critical appraisal","volume":"44","author":"Toutain","year":"2021","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.rvsc.2023.03.026_bb0270","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0275","article-title":"Population pharmacokinetics of intravenous amoxicillin combined with clavulanic acid in healthy and critically Ill dogs","volume":"8","author":"Vegas","year":"2021","journal-title":"Front. Vet. sci"},{"issue":"5","key":"10.1016\/j.rvsc.2023.03.026_bb0280","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jvp.12802","article-title":"Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs","volume":"42","author":"Wang","year":"2019","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.rvsc.2023.03.026_bb0285","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2885.2001.00357.x","article-title":"Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats","volume":"24","author":"Waxman","year":"2001","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.rvsc.2023.03.026_bb0290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2885.2003.00462.x","article-title":"Influence of Escherichia coli endotoxin-induced fever on the pharmacokinetic behavior of marbofloxacin after intravenous administration in goats","volume":"26","author":"Waxman","year":"2003","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.rvsc.2023.03.026_bb0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2885.2004.00548.x","article-title":"Age-related changes in the pharmacokinetics of marbofloxacin after intravenous administration in goats","volume":"27","author":"Waxman","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.rvsc.2023.03.026_bb0300","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/bcp.14278","article-title":"A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: prediction of infant drug exposure through breast milk","volume":"86","author":"Weisskopf","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0305","series-title":"Critically important antimicrobials for human medicine: Ranking of antimicrobial agents for risk management of antimicrobial resistance due to non-human use. 6th Revision. WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR)","author":"WHO (World Health Organization)","year":"2018"},{"issue":"6","key":"10.1016\/j.rvsc.2023.03.026_bb0310","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/jvp.12812","article-title":"Physiologically based modelling of the pharmacokinetics of three beta-lactam antibiotics after intra-mammary administration in dairy cows","volume":"42","author":"Woodward","year":"2019","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.rvsc.2023.03.026_bb0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12033-007-9024-5","article-title":"Cloning, sequence and functional analysis of goat ATP-binding cassette transporter G2 (ABCG2)","volume":"39","author":"Wu","year":"2008","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.rvsc.2023.03.026_bb0320","first-page":"653","article-title":"The PK\/PD interactions of doxycycline against Mycoplasma gallisepticum","volume":"7","author":"Zhang","year":"2016","journal-title":"Front. Microbiol."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528823000991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528823000991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:29:15Z","timestamp":1758515355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528823000991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":62,"alternative-id":["S0034528823000991"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2023.03.026","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics and pharmacokinetic\/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2023.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}